Skip to content

Mike Cordonnier, CEO, Carlsmed | Onyx Live | JPM 2026

Hundreds of thousands of spine fusions are performed each year, but implant choice is still often limited to standard sizes.

1 min read
Table of Contents

Hundreds of thousands of spine fusions are performed each year, but implant choice is still often limited to standard sizes. That is the gap patient-specific spine surgery is trying to close, and Carlsmed is building for that shift with its AI-enabled personalized platform.

In published data across 500+ patients, 82% of personalized levels achieved target alignment within 5°, and 96% showed zero subsidence at one year.

Commercially, the company reported $50.5M in 2025 revenue, up 85.9% year over year, with 75.3% gross margins.

More recently, it expanded its ecosystem with the first bilateral posterior lumbar procedure, the first corra cervical plating case, and a reported 6-day lead time for aprevo implants.

At JPM 2026, Onyx sat down with CEO Mike Cordonnier to find out more.

I hope you enjoy watching!

Yours sincerely,
Dr. Adil Ali

Comments